Kimberly Stegmaier

Kimberly Stegmaier, MD, is Chair of the Department of Pediatric Oncology, Dana-Farber Cancer Institute; Associate Chief, Division of Hematology/Oncology at Boston Children’s Hospital; Professor of Pediatrics at Harvard Medical School; and currently the Ted Williams Chair at Dana-Farber Cancer Institute. She has been a faculty member at Dana-Farber Cancer Institute, Boston Children’s Hospital, and Harvard Medical School since 2002 and an independent investigator since 2006. Dr. Stegmaier is dedicated to the goal of precision pediatric oncology medicine, pioneering the development and application of innovative genomic approaches to identify new therapies for childhood cancer. She has focused her efforts on acute leukemias and pediatric solid tumors of childhood — particularly those driven by fusion oncoproteins. Her lab has discovered novel technologies, concepts, and targets with translational impact.

Dr. Stegmaier received her undergraduate degree from Duke University, and medical degree from Harvard Medical School, and completed training in Pediatrics and Pediatric Hematology/Oncology at Boston Children’s Hospital and Dana-Farber Cancer Institute.